Cephalon's Nuvigil Jet Lag Indication Grounded By Complete Response Letter
Wall Street analysts question the extent to which the FDA move is a setback, given the outlook for the company's wakefulness franchise.
Wall Street analysts question the extent to which the FDA move is a setback, given the outlook for the company's wakefulness franchise.